Investor Day

November 8, 2018 Transportation & Advanced Polymers

ProductRandy Stone, or business President name TRANSPORTATION & ADVANCED POLYMERS KEY MESSAGES

Transforming Industries and Improving Lives through Material Science

Superior Financial › 12% Annual revenue growth* › 20% Annual adjusted operating EBITDA growth** Performance* › >360 Basis point margin improvement**

Specialty › 95% Product line is specialty, engineered, or custom-formulated › 50% Increase in growth capital for high return businesses Product Line › 39 Global manufacturing assets, strong and balanced regional footprint

Advantaged › #1 Leadership position in Automotive, Electronics, Industrial & Consumer › >2X Growth rate above global autobuilds Market Positions › ~3,000 Customer development projects to drive growth

2016 and 2017 financial information is on a pro forma basis *Represents results from 2016-2018E DuPont Transportation & Advanced Polymers 2 **Adjusted operating EBITDA excludes non-operating pension/OPEB costs TRANSPORTATION & ADVANCED POLYMERS OVERVIEW

LARGE & PROFITABLE (2018E) NET SALES (2018E)

BY BUSINESS SOURCES OF COMPETITIVE ADVANTAGE $5.7B 29% › Leading customer positions in high growth markets NET SALES ADJUSTED OP. › Innovation based on advantaged technology platform, 29% application development capabilities EBITDA MARGIN Performance Solutions 47% Performance Resins › Specialty product portfolio Engineering Polymers 24% 29% 24% GROWTH STRATEGY 41% › Extend leadership in attractive growth markets including auto electrification and healthcare 6% › Disciplined capital deployment BY MARKET SEGMENTS › Drive innovation portfolio Automotive 4% 5% Advanced Mobility 16% 34% PEERS Electronics › 3M Industrial › EMS 18% ~5,300 39 Healthcare COLLEAGUES MANUFACTURING 23% › Hexcel SITES Consumer › Victrex

DuPont Transportation & Advanced Polymers 3 Adjusted operating EBITDA excludes non-operating pension/OPEB costs STRONG GLOBAL BUSINESSES

Performance Resins Engineering Polymers Performance Solutions

Unique products & technology and deep Unrivaled engineering plastics portfolio, Highly differentiated specialty businesses application expertise for highly global presence and leading formulation, in critical industry applications with ValueProposition demanding applications design and processing expertise secular market growth

® ® › Betamate® › Molykote® › Delrin® › Vamac® › › Crastin ® ® › Betaseal® › Kalrez® › Hytrel® › Multibase › Zytel HTN › Rynite ® › Specialty › Filaments › Medical › Silicones Brands

Market Growth Market Growth Market Growth GDP+ GDP+ ~2x GDP

DuPont Transportation & Advanced Polymers 4 Source: Internal DuPont estimates ADDRESSING THE WORLD’S MOST CRITICAL NEEDS

Market Global Megatrends Our Solution Space Size** Automotive Automotive Nearly half of cars › Lightweighting › Crash safety $12B Electrification will be H/E by 2030 › Fuel efficiency & EV › Comfort range Future Mobility › Structural adhesives, › Materials for power, thermal management for infrastructure, signal $6B Renewability/ batteries electronics Sustainability 70% higher content* Electronics › Semiconductor › Signal electronics manufacturing › Handheld devices $3B › Connectors, cables 1.1 billion 5G Connectivity connections by 2025 Industrial & Consumer › Connected appliances › Oil & gas $4B › Aero engines

Health and 65+ population Healthcare Wellness doubles by 2030 › Medical devices › Transdermal drug $1B › Bio pharma processing delivery

*Additional revenue content per vehicle increase in hybrid / electric cars versus ICE ** 2017 addressable market size DuPont Transportation & Advanced Polymers 5 Source: IHS Data; Internal DuPont estimates FUTURE MOBILITY DRIVES REVENUE GROWTH REVENUE PER VEHICLE INCREASES BY >50% FROM INTERNAL COMBUSTION ENGINES TO ELECTRIC VEHICLES

ICE $190-$200/vehicle

Hybrid $300-$320/vehicle

BEV $320-$340/vehicle

ICE = Internal Combustion Engine DuPont Transportation & Advanced Polymers 6 BEV = Battery Electric Vehicle Source: Internal DuPont estimates DUPONT MOBILITY SOLUTIONS TO MOVE AHEAD™

Future Mobility Time / Requirements Industry Needs Progression to Scale* DuPont Capabilities

HYBRID / EV Ongoing

PARTIAL Ongoing AUTOMATION • CONNECTIVITY • ADHESIVES

2022-24 • ARAMIDS • LIGHTWEIGHTING ELECTRIC Battery range; Total VEHICLES • THERMAL Cost of Ownership • ELECTRONIC MATERIALS MANAGEMENT • DISPLAY TECHNOLOGIES 2028-30 COMPLETE • NOISE, VIBRATION, Regulation; AUTOMATION AND HARSHENESS Infrastructure • ENGINEERING POLYMERS • SILICONES • SAFETY 2030 SHARED Insurance Liability; MOBILITY Consumer Acceptance

DuPont Transportation & Advanced Polymers 7 * Scale defined as 20% of new yearly car build penetration or 20% of total miles driven PROVIDING INDUSTRY LEADING INNOVATION KALREZ® & VESPEL® HIGH PERFORMANCE PARTS

KALREZ® VESPEL®

STRONG GROWTH STRONG GROWTH

Profitable & Growing Profitable & Growing Market Market ~10% ~8% CAGR growth until 2022 CAGR growth until 2022

Value Proposition Value Proposition

› Specialty seals for the most demanding applications › Custom engineered solutions for challenging wear and friction › Resistant to 1,800 chemicals applications › Withstands temperatures up to 325 degrees Celsius › Non-melting engineering plastic – stable up to 370 degrees Celsius

Source: Internal DuPont estimates DuPont Transportation & Advanced Polymers 8 DELIVERING COST & GROWTH SYNERGIES

Combining the strengths & capabilities of two GROWTH SYNERGY DRIVERS leading portfolios to drive innovation in mobility, healthcare, electronics, and industrials Cross-Technology Innovation

› Complementary automotive portfolio enhances Cross-Selling Opportunities leadership position in auto electrification Market Leadership › Healthcare market leadership in silicones provides access to expand engineered Capacity Expansion / Release polymers solutions for Growth Businesses

› Differentiated automotive systems solutions by combining engineered polymers and adhesives COST SYNERGIES Innovation › Increased manufacturing productivity Platforms › Unique healthcare wearable device solutions using engineered polymers, silicones, and › Site consolidations adhesives

DuPont Transportation & Advanced Polymers 9 DRIVING SUSTAINABLE TOP & BOTTOM LINE GROWTH

FINANCIAL SUMMARY ($ BILLIONS) MEDIUM-TERM OUTLOOK

$5.1 $5.7 $4.5 NET 1.5x GDP growth SALES › Accelerate volume growth through 12% CAGR capacity release 2016A 2017A 2018E Sales Growth › Mix enrichment strategy for core products $1.6 $1.3 ADJUSTED $1.1 › Delivery of innovation pipeline projects OPERATING and growth synergy opportunities EBITDA 20% CAGR 2016A 2017A 2018E › Leverage lean operating model & productivity mindset 29% ADJ. OPERATING Operating › Maintain strategic pricing capability 25% 26% EBITDA MARGIN Leverage through reliable supply and >360 bps segmentation improvement › Accelerate digital transformation 2016A 2017A 2018E

Note: 2016 and 2017 financial information is on a pro forma basis DuPont Transportation & Advanced Polymers 10 Adjusted operating EBITDA excludes non-operating pension/OPEB costs Investor Day

November 8, 2018 Electronics & Imaging

ProductJim Fahey, or business President name ELECTRONICS & IMAGING KEY MESSAGES

World-leading electronic materials portfolio enabled by expertise in integrating materials to meet customer needs, global market presence and best-in-class manufacturing capabilities

› Market trends such as AI, IoT, 5G, autonomous vehicles and smart cities/homes Robust and Multi- are all accelerating Faceted End Market › These market trends are enabled by Moore’s Law Demand › Moore’s Law has and will continue to be driven by novel materials

› Key design partner with leading OEMs Enabling › Uniquely positioned to win through innovative products, deep customer Differentiation intimacy, and materials integration capabilities Through Innovation › Largest portfolio of products in the semiconductor industry

› Completion of CMP expansion in Taiwan Driving Continued › Expansion in manufacturing for semi and display in Korea Shift to Asia › Headcount additions concentrated in Asia (50% R&D located in Asia)

DuPont Electronics & Imaging 12 ELECTRONICS & IMAGING OVERVIEW

LARGE & PROFITABLE (2018E) NET SALES (2018E)

BY BUSINESS SOURCES OF COMPETITIVE ADVANTAGE $4.8B 39% › Innovation capabilities 5% Semiconductor Tech NET SALES ADJUSTED OP. 11% › Advantaged product portfolio Interconnect Solutions EBITDA MARGIN 35% › Strong customer relationships Photovoltaic and Advanced 23% Materials Advanced Printing 10% 23% 26% Display Tech GROWTH STRATEGY 65% › Leadership position in growth markets 2% › Broad portfolio with differentiated strategies BY MARKET SEGMENTS › Investment plans in attractive markets

6% Industrial 6% Communications 31% PEERS 15% Consumer › 3M Data Processing › Versum 16% ~6,000 40 Automotive COLLEAGUES MANUFACTURING 26% › Cabot Microelectronics SITES Mil/Aerospace › Entegris

Adjusted operating EBITDA excludes non-operating pension/OPEB costs DuPont Electronics & Imaging 13 STRONG GLOBAL BUSINESSES

Semiconductor Photovoltaics & Interconnect Solutions Advanced Printing Display Technologies Technologies Advanced Materials

Advanced materials for integrated Metallization, imaging, surface Materials to increase the lifetime Flexographic printing solutions for Materials for display applications, chip fabrication and packaging to treatments and films to enable and power output of solar consumer packaging, and digital OLED materials, quantum dots,

ValueProposition enable improved connectivity, smaller and multi-functional modules. Films and pastes are printing inks for textile, and display process chemicals to power, functionality and printed circuit boards also used in industrial applications commercial, home and office improve brightness, color performance such as sensors, wearable applications saturation, viewing angle and light electronics and protective films management

› Ikonic™ › ® › Tedlar® › Cyrel® › Optiline™ › Riston® › Solamet® › Trevista® › Artistri®

› AR™ 201 › Pyralux® › Intexar® Brands

Market Growth Market Growth Market Growth Market Growth Market Growth ~ 2x GDP GDP+ GDP+ GDP+ > 5x GDP

Source: Internal DuPont estimates DuPont Electronics & Imaging 14 ADDRESSING THE WORLD’S MOST CRITICAL NEEDS

Market Global Megatrends Our Solution Space Size* Semiconductor Technologies Artificial intelligence › Smart phones › Automotive › PCs & servers › Data storage $8B Ubiquitous Connectivity

Internet of things Interconnect Materials › PCs › Automotive $5B › Smart phones › Servers Enhanced User Experience 5G Photovoltaics & Advanced Materials › PV modules › Military & aerospace $6B › Automotive Smart cities Future Mobility Advanced Printing Materials › Textile printing › Industrial printing $3B Flexible electronics › Consumer digital printing Environment Display Materials › OLED smartphones › LEDs Autonomous driving › LCD displays $2B

* 2017 materials addressable market size DuPont Electronics & Imaging 15 Source: Internal DuPont estimates PROVIDING INDUSTRY LEADING INNOVATION

IoT and Artificial Intelligence 5G Infrastructure

STRONG GROWTH STRONG GROWTH

Large & Growing New Market Market > 20% $3.5B CAGR growth until 2022 Market Opportunity by 2022

Key Strengths Leveraged Key Strengths Leveraged

› IC and advanced packaging materials › High reliability circuit materials for ultra reliable low latency › Flexible & foldable films for substrates and displays applications › Solutions for improved performance and energy efficiency › High resolution display materials for AR/VR › Thermal management solutions › Advanced low-loss dielectrics and high resolution metallization › Thermal management solutions

Sources: McKinsey, Gartner, BCG; Yole Development, SNS Research DuPont Electronics & Imaging 16 DELIVERING COST & GROWTH SYNERGIES

SUCCESS STORIES MORE SOLUTIONS ACROSS THE COMPLETE VALUE CHAIN

KEY ACTIONS

› Amplify sales of existing products leveraging market channels CMPT Kapton® Dielectric Smart & EKC Film Infrastructure › Integrate heritage technology programs to build novel materials solutions › Continue › Expanding use of › Development of › Materials for next investment and polyimide highly differentiated generation smart localization in Asia dielectrics at higher materials for the devices & (Taiwan and frequencies 5G space infrastructure COST SYNERGIES Korea) › Synergistic growth › Synergistic growth › Collaborating › Consolidating offices and R&D sites in each › Synergistic growth focused on by leveraging across multiple country/region through leveraging leveraging internal internal materials, businesses and customers and materials, design integration product lines › Leveraging contract manufacturing network in market channels expertise and expertise and Asia across CMP, Litho market channel capacity availability & EKC

DuPont Electronics & Imaging 17 DRIVING SUSTAINABLE TOP & BOTTOM LINE GROWTH

FINANCIAL SUMMARY ($ BILLIONS) MEDIUM-TERM OUTLOOK

$4.8 $4.8 $4.3 NET 1.5x GDP driven by: SALES 6% CAGR Sales › Market trends driving growth of new 2016A 2017A 2018E Growth applications and materials needs › Design partner at key OEMs $1.4 $1.8 $1.9 ADJUSTED OPERATING EBITDA 14% CAGR 2016A 2017A 2018E › New products commanding higher price points Operating 33% 39% 39% ADJ. OPERATING Leverage › Continued cost productivity EBITDA MARGIN › Unique scale and channel access >550 bps improvement 2016A 2017A 2018E

Note: 2016 and 2017 financial information is on a pro forma basis Adjusted operating EBITDA excludes non-operating pension/OPEB cost DuPont Electronics & Imaging 18 2018 net sales growth negatively impacted by SKC Haas divestment Investor Day

November 8, 2018 Safety & Construction

ProductRose Lee, or businessPresident name SAFETY & CONSTRUCTION KEY MESSAGES

A global leader providing highly engineered solutions for essential needs of water, shelter and safety across a wide variety of end markets

Strong Market › Solving world’s challenges in water, shelter, and safety › Market leader based on proven track record, global scale and expertise Leadership › Investing in capacity expansion and accelerating innovation

Highly › Unique technology and brand platforms Differentiated › New application development powered by deep market intimacy Offerings › Strong value chain partnerships in all regions

Solid Trajectory › Differential pricing and portfolio actions for Margin › Operational reliability and productivity gains Expansion › Strategic sourcing partnerships and supply chain simplification

DuPont Safety & Construction 20 SAFETY & CONSTRUCTION OVERVIEW

LARGE & PROFITABLE (2018E) NET SALES (2018E)

BY BUSINESS SOURCES OF COMPETITIVE ADVANTAGE $5.5B 25% › Global market reach and credibility NET SALES ADJUSTED OP. 19% Aramids › Technical depth linked with market intimacy 29% EBITDA MARGIN › Strong, global brands Construction

23% 27% 43% 29% Water GROWTH STRATEGY 26% › Business simplification 4% › Disciplined capital deployment BY MARKET SEGMENTS › Innovation acceleration Construction

19% Personal Protective Equipment PEERS 34% Transportation 11% › Honeywell Medical 5% › 3M ~7,000 42 Industrial/Other COLLEAGUES MANUFACTURING 12% 19% › Hexcel Water SITES › Kimberly-Clark

DuPont Safety & Construction 21 Adjusted operating EBITDA excludes non-operating pension/OPEB costs STRONG GLOBAL BUSINESSES

Aramids Construction Tyvek® Enterprise Water Solutions

Unmatched leader in essential From foundation to attic, our Tough, durable, breathable Innovators in purification, ValueProposition lightweight strength, durability, portfolio of insulation, sealants materials that enable unique filtration and separation thermal and electrical and weatherization products solutions for protecting people, technologies, setting industry protection solutions across a deliver energy efficiency, goods and buildings standards for quality and diverse array of industries and durability and comfort reliability applications

› Styrofoam™ › Taptec™ › ® › Corian® › Tyvek® › Filmtec™ › ®

Brands › Great Stuff™ › Amberlite™

Market Growth Market Growth Market Growth Market Growth GDP+ GDP+ > 1.5x GDP > 2x GDP

DuPont Safety & Construction 22 Source: BCG ADDRESSING THE WORLD’S MOST CRITICAL NEEDS

Market Global Megatrends Our Solution Space Size* Medical & Pharma Packaging › Medical Device › Pharma Cold Chain $4B Nearly half Packaging Packaging Of the global population could be facing water 1 scarcity by 2030 Water Sustainable Development › Residential, Industrial, › Specialty Processing $5B Wastewater Filtration 53% Global energy demand 2 growth by 2035 Aerospace & Automotive xEV › Aerospace Light › xEV Electrical & Thermal $3B 2 million Weighting Insulation Systems Target reduction in number of fatalities from occupational Construction accidents by 20303 › Building Thermal › Air-Sealing Protection $20B From Harm Management › Solid Surfaces › Weatherization 20% CAGR China’s medical device market growth per year4 Personal Protective Equipment › Chemical, Fire, Electrical, Biological and Ballistics $19B Protection

Sources: 1. OECD 2. U.S. Department of Energy 3. United Nations 4. Financial Times DuPont Safety & Construction 23 * 2017 addressable market size PROVIDING INDUSTRY LEADING INNOVATION

FILMTEC™ Residential Water Filtration Membrane Tyvek® 40L Medical Device Packaging

STRONG GROWTH STRONG GROWTH

Growing Market New Market ~20% ~$400MM CAGR growth until 2022 Market Opportunity

Key Strengths Leveraged Key Strengths Leveraged

› Most trusted brand in RO space with three decades of › A unique and competitive solution for medical packaging performance and three new products introduced this year challenges in Asia › Multi-Tiered offering, partnering with leading brand owners to › 1st Tyvek® global medical product designed for and launched customize solutions for their targeted consumers in China

DuPont Safety & Construction 24 Sources: BCG and internal estimates DELIVERING COST & GROWTH SYNERGIES

Combining the strengths & capabilities of two MARKET DRIVERS influential portfolios in building materials to drive innovative solutions Sustainable, Energy Efficient Structures

› Complementary portfolio enables new solutions in thermal comfort, structural protection and air sealing Broad Solution & weatherization Construction Productivity Portfolio › Increased end-user awareness and relevancy with our branded solutions

“Smart” Enablement & Sensing › Amplified market coverage leveraging DuPont’s residential market footprint and Dow’s commercial Market and retail market strength Leadership › Deep technical expertise in all major building types: concrete, timber and steel COST SYNERGIES › Market-intimacy led innovation focused on capturing › Manufacturing site consolidation and value by transforming building practices and driving productivity Innovation construction efficiencies Platforms › Well positioned to foster partnerships across the › Business process simplification value chain

DuPont Safety & Construction 25 DRIVING SUSTAINABLE TOP & BOTTOM LINE GROWTH

FINANCIAL SUMMARY ($ BILLIONS) MEDIUM-TERM OUTLOOK

$5.5 $5.1 NET $5.0 1.5x GDP driven by: SALES › Innovation acceleration 5% CAGR Sales 2016A 2017A 2018E Growth › Capacity expansion › Technical depth linked with market $1.4 intimacy ADJUSTED $1.2 $1.2 OPERATING EBITDA 4% CAGR 2016A 2017A 2018E › Operational reliability and productivity gains 25% 24% 25% Operating Leverage › Differential pricing and portfolio ADJ. OPERATING actions EBITDA MARGIN 2016A 2017A 2018E

Note: 2016 and 2017 financial information is on a pro forma basis DuPont Safety & Construction Adjusted operating EBITDA excludes non-operating pension/OPEB benefit 26 Investor Day

November 8, 2018 DuPont Industrial Biosciences

ProductWilliam orFeehery, business President name INDUSTRIAL BIOSCIENCES KEY MESSAGES

World-leading position in the industrial technology space, accessing a broad set of markets, disrupting traditional chemical and material markets

› Leveraging world-leading biotechnology into and microbial solutions Biotechnology › Accelerating new product introductions with high throughput robotic Innovation experiments Pioneer › Breakthrough renewable polymer products enabled by › Strong pipeline of application and new product innovations

› Healthy pipeline of new-to-the-world molecules and formulated products Technology Driven › Significant cost reduction and capital avoidance via continuous improvement of Margin Expansion the “cell factory” › 40% revenue from new products introduced in the last 5 years

› Global leader in industrial biotechnology, enzymatic solutions, high performance Leader in Growing biomaterials and specialty microbial control Market Segments › Pursue robust growth of animal, plant and skin microbiome

DuPont Industrial Biosciences 28 INDUSTRIAL BIOSCIENCES OVERVIEW

LARGE & PROFITABLE (2018E) NET SALES (2018E)

BY BUSINESS SOURCES OF COMPETITIVE ADVANTAGE $2.2B › 25+ years of industrial biotechnology expertise 13% › Deep customer-focused application development NET SALES Bioactives › Large scale manufacturing and operational Biomaterials 24% 48% productivity Microbial Control › Regulatory expertise

26% 15% 41% Clean Technologies GROWTH STRATEGY 26% › Product innovation via cutting edge biotechnology

7% › Focus on high-growth markets › Rapid new product speed-to-market BY MARKET SEGMENTS › Capacity and margin expansion through technology advances 10% 17% Food & Bev 11% PEERS Animal Nutrition › Novozymes 16% Home & Personal Care 18% Energy & Water › Chr. Hansen ~2,800 19 › Lonza COLLEAGUES MANUFACTURING 28% Industrial SITES Textile › Croda

DuPont Industrial Biosciences 29 STRONG GLOBAL BUSINESSES

Bioactives Biomaterials Microbial Control Clean Technologies

Premier global industrial enzymes Successful enzyme-enabled Leading producer of main Primary technology provider to all business, with significant biotech biopolymer businesses, selling a microbial control agent in oil/gas industries requiring high-quality capability to genetically engineer highly differentiated specialty production; leading position in sulfuric acid with low microbes using big data, 3D polyester to the carpet and primary microbial control agent in ValueProposition environmental impact; engineering visualization and robotics; large apparel markets; world leading many personal care products; and design services, aftermarket manufacturing scale, global share in bio-PDO production; late- extensive microbiology, high parts, and catalyst supply footprint, and exposure to a wide stage pipeline of exciting new throughput testing and regulatory array of end markets biomaterials experience

› Synerxia® › Genencare® › Aqucar™ › Silvadur™ › Belco® › MECS® › Excellenz™ › Axtra® Phy › Zemea® › ® › Kathon™ › Stratco®

› Preferenz™ › Glutex™ › Isotherming® Brands

Market Growth Market Growth Market Growth Market Growth GDP+ ~ GDP GDP+ ~ GDP

Sources: Euromonitor, Bernstein, McKinsey, Freedonia, CRI, Intercontuft, BI Services, CRU, Platts and internal estimates DuPont Industrial Biosciences 30 ADDRESSING THE WORLD’S MOST CRITICAL NEEDS

Market Global Megatrends Our Solution Space Size* Industrial Biotechnology › Food and grain processing › Animal health and nutrition › Home and personal care › Carpet and apparel Hygiene Solutions $15B › Enzymes, yeast & › Enzymatic polysaccharides Health & probiotics Wellness › Specialty polyesters Health & nutrition Microbial Control › Energy and water › Home and personal care › Preservatives Comfort Solutions $7B › Specialty biocides

Sustainable processes & materials Sustainability Clean Technologies › FCC scrubbing › Acid and alkylation solutions Clean fuels & clean air Solutions $2B › Process technology and › Emissions control solutions equipment › Industry support solutions › Catalyst

* 2017 addressable market size DuPont Industrial Biosciences 31 Source: Internal estimates PROVIDING INDUSTRY LEADING INNOVATION

Enzymes Power Cold Water Washing Probiotics and Enzymes in Poultry Feed Energy Solutions

STRONG STRONG STRONG GROWTH GROWTH GROWTH

Large Market Expanding Market Large & Growing Market $1B ~$1B $1B Market Market Market Opportunity Opportunity Opportunity

Key Strengths Leveraged Key Strengths Leveraged Key Strengths Leveraged

› Best-in-class protein engineering technologies › Microbiome understanding, characterization, › Targeted microbial control to prepare, to create superior cold water performance selection, and custom formulation decontaminate and protect oil & gas (water, wells and reservoirs) › Deep application expertise in laundry shortens › Probiotics and enzymes reduce feed costs, time-to-market and improves success rate and enable healthier poultry › Integrated offering of yeast and enzymes that improve bioethanol production yield by >3% › Strong customer intimacy and collaboration › Reduced feed costs and increased farmer across all functions returns

Sources: Bernstein, MarketsandMarkets, internal and customer consensus estimates DuPont Industrial Biosciences 32 DELIVERING COST & GROWTH SYNERGIES

A POWERFUL COMBINATION OF CAPABILITIES ACCELERATES GROWTH IN HOME CARE

Laundry Malodor is an Emerging From DuPont Challenge for Consumers • Protein libraries • Probiotics From Dow • Microbial control Shorter wash cycles, lower wash temperatures and • Odor science synthetic fabrics are more favorable to microbial growth From both companies and malodor issues • Hygiene applications know-how • Regulatory expertise

Permastink Low Temp Funk COST SYNERGIES › Elimination of redundant lab and analytical Air Dry Stench Machine Odor capabilities › Site consolidation

DuPont Industrial Biosciences 33 DRIVING SUSTAINABLE TOP & BOTTOM LINE GROWTH

FINANCIAL SUMMARY ($ BILLIONS) MEDIUM-TERM OUTLOOK

$2.2

NET SALES $2.1 1.5x GDP growth driven by: 6% CAGR Sales › New products $1.9 Growth › Leadership positions in growth markets and regions

› Technology-driven higher value/lower cost products Operating › Product and customer segmentation Leverage › Efficiency of industrial-scale fermentation 2016A 2017A 2018E

Note: 2016 and 2017 financial information is on a pro forma basis DuPont Industrial Biosciences 34 Investor Day

November 8, 2018 Nutrition & Health

Matthias Heinzel, President NUTRITION & HEALTH KEY MESSAGES

World-leading provider of innovative and sustainable solutions for the food and health industry, offering the broadest portfolio across the food & beverage, dietary supplements and pharma excipients segments

Powerful and › Leading positions vs competition in key segments Sustainable Market › Broadest portfolio in the market Leadership › Unique route-to-market with strong customer access

› Combination of customer oriented application development and new product Outstanding platforms Innovation a Key › Differential portfolio management with focus on probiotics, cultures, HMO Strength (Human Milk Oligosaccharides), pharma excipients and microbiome › Metrics driven, strong pipeline management

› Proven track record of delivering profitable growth Positioned for Top- › Favorable secular markets with areas of high growth Line Growth & Margin › Proven, differentiated strategy and lean operating model to deliver strong Expansion operating leverage

DuPont Nutrition & Health 36 NUTRITION & HEALTH OVERVIEW

LARGE & PROFITABLE (2018E) NET SALES (2018E)

BY BUSINESS SOURCES OF COMPETITIVE ADVANTAGE $4.7B › Broad, market leading portfolio Probiotics, Cultures & Food › Innovation leadership with strong science foundation NET SALES 16% 17% Protection › Route-to-market and customer intimacy Pharma Excipients

22% 18% Systems & Texturants GROWTH STRATEGY 31% Protein Solutions › Focus on innovation to enable high-growth and high- 40% margin platforms 21% 27% Emulsifiers & Sweeteners › Disciplined capital allocation 8% › Efficient operation model › Active portfolio management BY MARKET SEGMENTS PEERS › Chr. Hansen Health & Wellness 35% › Kerry (includes dietary supplements and pharma) › Givaudan Food & Beverage › Int’l Flavors & Fragrances ~8,000 55 65% COLLEAGUES MANUFACTURING SITES

DuPont Nutrition & Health 37 STRONG GLOBAL BUSINESSES

Probiotics & Pharma Systems & Emulsifiers & Protein Solutions Cultures Excipients Texturants Sweeteners

Serving global Meeting drug delivery First choice for High-quality and Solutions for efficient, demand for healthy, needs through healthy, application-specific functional food natural and fermented innovative convenient and functionality for emulsification and ValueProposition food & supplements solutions and close affordable foods that nutritionally and cost- natural specialty market collaboration feel and taste great beneficial soy protein sweeteners

® TM ® ® › › Methocel › Danisco › Danisco › Danisco® ® ® ® ® › Howaru › Avicel › Grindsted › Supro Max › Grindsted® ® ® › Choozit › Supro › SolecTM Nuggets › Xivia®

Brands › Supro® XT Market Growth1) Market Growth2) Market Growth3) Market Growth4) Market Growth5) > 2.5x GDP > 1.5x GDP GDP+ GDP+ ~ GDP

Sources: 1) Euromonitor, Nielsen, 2) BCG, BCC, Goldman Sachs, Technavio, 3) Euromonitor, Trade Data, BCC, DuPont Nutrition & Health IMR, Martec, SAI, 4) Euromonitor, Trade Data, Martec, 5) Euromonitor, Trade Data BCC, Giract 38 ADDRESSING THE WORLD’S MOST CRITICAL NEEDS

Market Global Megatrends Our Solution Space Size*

Food & Beverage › Dairy Nutrition for healthy › Beverages living › Bakery $10B › Confectionary and snacks Growing & › Frozen desserts and fruit applications Aging Smaller & local brands › Meat and poultry Population winning

Demand for clean label Dietary Supplements Health & › Probiotics – concentrates Wellness › Probiotics – finished formats $2B Focus › Microbiome solutions Preventative health › Nutraceuticals

Health Next generation pharma Solutions ingredients Access & Pharma Excipients Affordability › Immediate release tablets Industrialization of food › Controlled release tablets in emerging markets › Hard capsules $3.5B › Non-gelatine, vegan soft capsules › Enterics and solubility enhancement › Anti-reflux

Sources: Euromonitor, BCC, Trade Data, Martec, IMR, Giract, 3A, Blimling, NBJ, Nielsen, BCG, Goldman Sachs, Technavio, Company reports DuPont Nutrition & Health 39 * 2017 addressable market size PROVIDING INDUSTRY LEADING INNOVATION

Probiotics: Creating a Health Category HMO: The Next Step in Infant Formulation Pharma Excipients: Free-From Capsules

The Core: STRONG Infant STRONG STRONG GROWTH Nutrition GROWTH GROWTH

Next Tier: Large & Toddler & Adult Health New Market Trending Market Growing Market ~8% ~7-8% ~$1B Annual growth Probiotics annual Market gelatin-free growth rate1) Opportunity2) capsules market3)

Key Strengths Leveraged Key Strengths Leveraged Key Strengths Leveraged

› Cultures expertise and strong science › Reputation for quality and safety › Combined excipient know-how used to foundation › Innovation skills and probiotics leadership develop gelatin-free capsules › Global consumer insights › External partnerships and Industrial › Expertise and formulation skills from soft gels › Committed investment strategy for continued Biosciences collaboration and hard capsules growth › Global market reach

Sources: 1) Euromonitor, 2) Euromonitor, 3) Newry DuPont Nutrition & Health 40 DELIVERING COST & GROWTH SYNERGIES

Bringing Together Three Winning Businesses Creates a Unique Value Proposition

% of Food & Dietary Pharma Revenue Beverage Supplements Excipients (2018E)

...and growth and cost synergies

Innovation Capabilities Lean Business Structure Example: Example: Improve Formulation Expertise Operations & Sourcing In-sourcing of probiotics with cellulosics for pharma Channel Reach Lower Overhead Costs higher-value excipients functional expertise systems Growth Platform Office & Warehouse Consolidation

Growth Cost

DuPont Nutrition & Health 41 DRIVING SUSTAINABLE TOP & BOTTOM LINE GROWTH

FINANCIAL SUMMARY ($ BILLIONS) MEDIUM-TERM OUTLOOK

$6.9 $5.7 $6.0 $2.2 NET $1.9 $2.1 1.5x GDP driven by: SALES IB $3.8 $3.9 $4.7 9% CAGR N&H › Underlying market growth driven by consumer trends 2016A 2017A 2018E Sales Growth › Outstanding innovation strength $1.6 ADJUSTED $1.3 $1.3 › Global customer intimacy and OPERATING footprint in emerging regions EBITDA 13% CAGR 2016A 2017A 2018E

› Lean operating model 22% 22% 24% ADJ OPERATING Operating EBITDA MARGIN Leverage › Portfolio investments in high growth/high margin markets >160 bps improvement 2016A 2017A 2018E

Note: 2016 and 2017 financial information is on a pro forma basis Operating EBITDA excludes non-operating pension/OPEB costs DuPont Nutrition & Health 42 2018 N&H results benefitting from FMC H&N acquisition Safe Harbor Statement

This presentation contains “forward-looking statements” within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In this context, forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as “expect,” “anticipate,” “intend,” “plan,” “believe,” “seek,” “see,” “will,” “would,” “target,” “objective,” and similar expressions and variations or negatives of these words.

Forward-looking statements by their nature address matters that are, to different degrees, uncertain, such as statements about the internal reorganization of DowDuPont’s agriculture, materials science and specialty products businesses and the anticipated benefits thereof as well as the anticipated separation and distribution of Corteva Inc. (“Corteva”) and Dow Holding Inc. (“Dow”). These and other forward-looking statements, including the failure to complete, or to make any filing or take any other action required to be taken to complete, the separations and distributions are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause actual results to differ materially from those expressed in any forward-looking statements. Forward-looking statements also involve risks and uncertainties, many of which are beyond our control. Some of the important factors that could cause the actual results of DuPont to differ materially from those projected in any such forward-looking statements include, but are not limited to (i) changes in credit ratings, (ii) risks associated with international sales and operations, (iii) availability, and variable costs, of raw materials and energy, (iv) competitive conditions and customer preferences, (v) the costs of complying with evolving regulatory requirements, (vi) disruptions to supply chains, information technology or network systems, (vii) protection of intellectual property, (viii) concerns regarding chemicals in commerce, including their environmental impact, (ix) failure to comply with government regulations, (x) impairments to goodwill or intangible assets, (xi) failure to effectively manage acquisitions, divestitures, alliances and other portfolio actions, (xii) litigation and other commitments and contingencies, (xiii) subjection to laws, regulations and mandates globally, (xiv) failure to increase productivity through sustainable operational improvements, (xv) the dependence of tax liabilities upon the distribution of income among the various jurisdictions in which we operate and (xvi) failure of risk management strategies. Risks related to the separations and distributions and to achieving the anticipated benefits thereof include, but are not limited to, a number of conditions which could delay, prevent or otherwise adversely affect the separations and distributions, as well as other risks, including risks related to (i) our inability to achieve some or all of the benefits that we expect to receive from the separations and distributions, (ii) certain tax risks associated with the separations and distributions, (iii) our inability to make necessary changes to operate as a stand-alone company following the separations and distributions, (iv) the failure of our pro forma financial information to be a reliable indicator of our future results, (v) our inability to enjoy the same benefits of diversity, leverage and market reputation that we enjoyed as a combined company, (vi) restrictions under the intellectual property cross-license agreements, (vii) our inability to receive third-party consents required under the separation agreement, (viii) our customers, suppliers and others’ perception of our financial stability on a stand-alone basis, (ix) non-compete restrictions under the separation agreement, (x) receipt of less favorable terms in the commercial agreements we will enter into with Dow and Corteva than we would have received from an unaffiliated third party and (xi) our indemnification of Dow and/or Corteva for certain liabilities. We assume no obligation to publicly provide revisions or updates to any forward-looking statements, whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws.

Additionally, this presentation includes certain estimates, objectives and targets that are forward-looking and subject to significant business, economic, regulatory and competitive uncertainties and contingencies, many of which are beyond our control, and are based upon assumptions with respect to future decisions, which are subject to change. Actual results will vary and those variations may be material. Nothing in this presentation should be regarded as a representation by any person that these objectives will be achieved and we undertake no duty to update this information, except as otherwise required by securities and other applicable laws.

For further discussion of certain important factors that could cause variations in our forward-looking statements, please consult the “Risk Factors” section of the most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q of DowDuPont, The Dow Chemical Company (“Historical Dow”) and E. I. du Pont de Nemours and Company (“Historical DuPont”), as well as the current reports and other information that DowDuPont, Historical DuPont, Historical How, Dow or DuPont may file with the Securities and Exchange Commission from time to time.

43 Safe Harbor Statement, continued

Non-GAAP Information: This presentation includes information that does not conform to U.S. GAAP and are considered non-GAAP measures. These measures include operating EBITDA and operating EBITDA margin, and pro forma operating EBITDA and pro forma operating EBITDA margin, as adjusted by removing expense/benefits associated with non-operating pension and other postemployment benefits (OPEBs). We believe that these non-GAAP measures best reflect the ongoing performance of DuPont during the periods presented and provide more relevant and meaningful information to investors as they provide insight with respect to ongoing operating results of the DuPont and a more useful comparison of year-over-year results. These non-GAAP measures supplement our U.S. GAAP disclosures and should not be viewed as an alternative to U.S. GAAP measures of performance. Furthermore, such non-GAAP measures may not be consistent with similar measures provided or used by other companies. Reconciliations for these non-GAAP measures to GAAP are included in this presentation or on the company’s website.

Divisional Information: Discussion of DuPont net sales, adjusted operating EBITDA, including on a pro forma basis, and price/volume metrics on a divisional and segment basis is based on the combined and separate results of and estimates for DowDuPont’s Electronics & Imaging, Nutrition & Biosciences, Transportation & Advanced Polymers, and Safety & Construction segments. Information for the years ended December 31, 2017 and 2016 are presented on a pro forma basis as though the merger of Historical Dow and Historical DuPont had occurred on January 1, 2016. This information is presented in this manner for informational purposes only and should not be viewed as an indication of DuPont’s current or future operating results on a standalone basis assuming completion of the intended business separations. Full Year 2018 Estimates for Net Sales, Adjusted Operating EBITDA and Adjusted Operating EBITDA Margin (collectively, the “FY2018 Estimates”) are based on forward- looking information provided in connection with DowDuPont’s third quarter 2018 earnings announcement (“DowDuPont’s FY2018 Guidance”) for results of operations for DowDuPont’s Specialty Products Division and the segments that comprise it: Electronics & Imaging, Nutrition & Biosciences, Transportation & Advanced Polymers, and Safety & Construction, and the relative contribution of each such segment to divisional results of operations. FY2018 Estimates are not intended to and should not be interpreted as updating DowDuPont’s FY2018 Guidance.

Unaudited Pro Forma Financial Information: The unaudited pro forma financial information included in this presentation is based on the historical consolidated financial statements and accompanying notes of DowDuPont, Historical Dow and Historical DuPont and has been prepared to illustrate the effects of the merger, assuming the merger had occurred on January 1, 2016. For all periods presented prior to January 1, 2018, adjustments have been made for (1) the preliminary purchase accounting impact, (2) accounting policy alignment, (3) eliminate the effect of events that are directly attributable to the merger agreement (e.g., one-time transaction costs), (4) eliminate the impact of transactions between Dow and DuPont, and (5) eliminate the effect of consummated divestitures agreed to with certain regulatory agencies as a condition of approval for the merger. The unaudited pro forma financial information was based on and should be read in conjunction with the separate historical financial statements and accompanying notes contained in each of Historical Dow’s and Historical DuPont’s Quarterly Reports on Form 10-Q and Annual Reports on Form 10-K for the applicable periods. The pro forma financial statements were prepared in accordance with Article 11 of Regulation S-X. The unaudited pro forma financial information has been presented for informational purposes only and is not necessarily indicative of what DuPont's results of operations actually would have been had the Merger had been completed as of January 1, 2016, nor is it indicative of the future operating results of DuPont as a standalone public company.

44 Non-GAAP Reconciliation

45 Non-GAAP Reconciliation

46